Mengqiu Song - Search Results

Year	Number of Results
2017	3
2018	4
2019	4
2020	6
2021	2
2023	5
2024	2

1

Song M, Bode AM, Dong Z, Lee MH. Song M, et al. Cancer Res. 2019 Mar 15;79(6):1019-1031. doi: 10.1158/0008-5472.CAN-18-2738. Epub 2019 Feb 26. Cancer Res. 2019. PMID: 30808672 Review.

2

Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.

Song M, Pang L, Zhang M, Qu Y, Laster KV, Dong Z. Song M, et al. Signal Transduct Target Ther. 2023 Apr 7;8(1):148. doi: 10.1038/s41392-023-01409-4. Signal Transduct Target Ther. 2023. PMID: 37029108 Free PMC article. Review.

3

NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway.

Yin S, Zhao S, Li J, Liu K, Ma X, Zhang Z, Wang R, Tian J, Liu F, Song Y, Song M, Zhao R, Yang R, Lee MH, Dong Z. Yin S, et al. Among authors: song m. Cell Mol Life Sci. 2023 Jul 18;80(8):211. doi: 10.1007/s00018-023-04854-0. Cell Mol Life Sci. 2023. PMID: 37462735

4

Targeting endoplasmic reticulum associated degradation pathway combined with radiotherapy enhances the immunogenicity of esophageal cancer cells.

Luo H, Sun Y, Wang L, Liu H, Zhao R, Song M, Ge H. Luo H, et al. Among authors: song m. Cancer Biol Ther. 2023 Dec 31;24(1):2166763. doi: 10.1080/15384047.2023.2166763. Cancer Biol Ther. 2023. PMID: 36907982 Free PMC article.

5

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint.

Gu T, Tian X, Wang Y, Yang W, Li W, Song M, Zhao R, Wang M, Gao Q, Li T, Zhang C, Kundu JK, Liu K, Dong Z, Lee MH. Gu T, et al. Among authors: song m. Front Immunol. 2023 May 2;14:1145028. doi: 10.3389/fimmu.2023.1145028. eCollection 2023. Front Immunol. 2023. PMID: 37205112 Free PMC article.

6

PIM Kinase as an Executional Target in Cancer.

Zhang X, Song M, Kundu JK, Lee MH, Liu ZZ. Zhang X, et al. Among authors: song m. J Cancer Prev. 2018 Sep;23(3):109-116. doi: 10.15430/JCP.2018.23.3.109. Epub 2018 Sep 30. J Cancer Prev. 2018. PMID: 30370255 Free PMC article. Review.

7

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.

Song M, Qu Y, Jia H, Zhang Y, Liu S, Laster KV, Choi BY, Tian J, Gu T, Chen H, Liu K, Lee MH, Dong Z. Song M, et al. Mol Carcinog. 2024 May;63(5):991-1008. doi: 10.1002/mc.23703. Epub 2024 Feb 20. Mol Carcinog. 2024. PMID: 38376345

8

Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells.

Shin SH, Lee JS, Zhang JM, Choi S, Boskovic ZV, Zhao R, Song M, Wang R, Tian J, Lee MH, Kim JH, Jeong M, Lee JH, Petukhov M, Lee SW, Kim SG, Zou L, Byun S. Shin SH, et al. Among authors: song m. Sci Adv. 2020 Jul 31;6(31):eaay9131. doi: 10.1126/sciadv.aay9131. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32789167 Free PMC article.

9

Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo.

Zhang M, Wang R, Tian J, Song M, Zhao R, Liu K, Zhu F, Shim JH, Dong Z, Lee MH. Zhang M, et al. Among authors: song m. J Cell Mol Med. 2021 Jun;25(12):5560-5571. doi: 10.1111/jcmm.16568. Epub 2021 May 13. J Cell Mol Med. 2021. PMID: 33982869 Free PMC article.

10

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.

Gu T, Zhao S, Jin G, Song M, Zhi Y, Zhao R, Ma F, Zheng Y, Wang K, Liu H, Xin M, Han W, Li X, Dong CD, Liu K, Dong Z. Gu T, et al. Among authors: song m. Front Immunol. 2021 Jan 28;11:621441. doi: 10.3389/fimmu.2020.621441. eCollection 2020. Front Immunol. 2021. PMID: 33584719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year